Clinical Research Informer

Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)

Rethinking Clinical Trials

JULY 27, 2022

ACTIV, ACTIV-6, COVID-19, Ivermectin, Inhaled Fluticasone. The post Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS) appeared first on Rethinking Clinical Trials. ? ? ? ? ? ? ?. Speaker. Susanna Naggie, MD, MHS. Professor of Medicine. Key Points.

Trials

Trials Pharmacy Medicine Clinical Trials

Grand Rounds February 3, 2023: Pragmatic Trials For Children With Congenital Heart Disease – Insights From The NITRIC Trial (Luregn Schlapbach, PhD, FCICM)

Rethinking Clinical Trials

FEBRUARY 13, 2023

All patients could receive inhalation NO during/after surgery if considered indicated by the treatment team. The intervention was applied by perfusionists at a steady concentration from the start until the end of bypass. All other surgical staff were blinded. There was no use of nitric oxide (NO) during CPB controls.

Trials

Trials Clinical Trials Clinical Trials Research

Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)

Grand Rounds February 3, 2023: Pragmatic Trials For Children With Congenital Heart Disease – Insights From The NITRIC Trial (Luregn Schlapbach, PhD, FCICM)

Stay Connected